These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25443512)

  • 21. Multistate fungal meningitis outbreak -- interim guidance for treatment.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(41):842. PubMed ID: 23076094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Response, Outbreak Investigation, and Epidemiology of the Fungal Meningitis Epidemic in the United States: Systematic Review.
    Abbas KM; Dorratoltaj N; O'Dell ML; Bordwine P; Kerkering TM; Redican KJ
    Disaster Med Public Health Prep; 2016 Feb; 10(1):145-51. PubMed ID: 26681583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal and paraspinal infections associated with contaminated methylprednisolone acetate injections - Michigan, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(19):377-81. PubMed ID: 23677044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iatrogenic fungal meningitis: tragedy repeated.
    Perfect JR
    Ann Intern Med; 2012 Dec; 157(11):825-6. PubMed ID: 23080380
    [No Abstract]   [Full Text] [Related]  

  • 28. Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013.
    Smith RM; Derado G; Wise M; Harris JR; Chiller T; Meltzer MI; Park BJ
    Emerg Infect Dis; 2015 Jun; 21(6):933-40. PubMed ID: 25989264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterile products: advances and challenges in formulation, manufacturing and regulatory aspects--a regulatory review perspective.
    Hussong D
    AAPS PharmSciTech; 2010 Sep; 11(3):1482-4. PubMed ID: 20845091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compounded steroids for epidural injections: what are the issues?
    Benzon HT
    Anesth Analg; 2013 Aug; 117(2):523-6. PubMed ID: 23881374
    [No Abstract]   [Full Text] [Related]  

  • 32. New England Compounding Center Indictment.
    Cabaleiro J
    Int J Pharm Compd; 2015; 19(2):94-102. PubMed ID: 26685489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes from the field: Department of Defense response to a multistate outbreak of fungal meningitis--United States, October 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Sep; 62(38):800-1. PubMed ID: 24067586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.
    Gupta N; Hocevar SN; Moulton-Meissner HA; Stevens KM; McIntyre MG; Jensen B; Kuhar DT; Noble-Wang JA; Schnatz RG; Becker SC; Kastango ES; Shehab N; Kallen AJ
    Clin Infect Dis; 2014 Jul; 59(1):1-8. PubMed ID: 24729502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When pharmacies cause harm.
    Jha VM
    Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132
    [No Abstract]   [Full Text] [Related]  

  • 37. Compounding botanicals: a legal perspective.
    Valentino JG; Bormel FG
    J Am Pharm Assoc (Wash); 1999; 39(4):537-44. PubMed ID: 10467820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 39. Fungal Diseases Caused by Serious Contamination of Pharmaceuticals and Medical Devices, and Rapid Fungal Detection Using Nano-Diagnostic Tools: A Critical Review.
    Ahmed MAEE; Abbas HS; Kotakonda M
    Curr Microbiol; 2023 Nov; 81(1):10. PubMed ID: 37978091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.